Let’s Build A Drug! Biopharma Startup Launches Crowdsourcing Tool To Pick Compounds

Stephanie Baum | MedCity News | October 24, 2012

A biopharma startup believes that when it comes to deciding what conditions it should develop drugs to treat, the decision should be left to a public vote.

New York based Transparency Life Sciences has launched a second crowdsourcing tool that asks users to choose from 58 clinical stage compounds posted by the NIH’s U.S. National Center for Advancing Translational Sciences. They can follow links to background information about each of the compounds and try different variations. It does caution users that the compounds they help select may become development projects for the business, according to its website. For any development projects it selects, it plans to use its inaugural crowdsourcing platform launched earlier this year for building the clinical trials.

Instructions on the company’s website add some guidance...